8,083 followers
#JITC Case Report: Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature https://t.co/YgVQmVnzOa https://t.co/pUDJ466Y3P
#JITC Case Report: Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature https://t.co/YgVQmVnzOa https://t.co/pUDJ466Y3P
RT @gulleyj1: When is it safe to rechallenge with ICI after irAE? https://t.co/0oo5hC00uv
RT @gulleyj1: When is it safe to rechallenge with ICI after irAE? https://t.co/0oo5hC00uv
RT @gulleyj1: When is it safe to rechallenge with ICI after irAE? https://t.co/0oo5hC00uv